The Innovation Support Center Advisory Panel provides industry "know-how" to translate drug discovery projects to commercial drug approvals. Our panel includes capabilities in the following areas:
- Preclinical and Clinical Planning
- Medicinal Chemistry
- Regulatory Strategy and Planning
- Discovery and Development Specialty Areas
- Business Development
Preclinical and Clinical Planning
Panel members with expertise in selecting and developing assays, animal models, structural models and clinical trials are assets to the successful and efficient discovery and development of therapeutics for clinical advancement.
Medicinal chemistry experts with decades of experience in the synthesis and alteration of organic compounds contribute to the discovery and optimization of lead compounds and series without claiming rights to any intellectual property. These industry veterans know how to help our scholars identify compounds with a high likelihood of becoming therapeutic agents.
Panel members with a strong background in pharmacology advise scholars on safety, toxicology, pharmacokinetics and pharmacodynamics, providing an expert eye to evaluate experimental results and suggest strategic next steps.
Regulatory Strategy and Planning
With an eye to the clinic, panel members with years of experience in regulatory strategy and planning offer an important perspective in guiding early discoveries toward investigational and marketing success.
Discovery and Development Specialty Areas
Advisors with specialty skills in key scientific and/or therapeutic areas lend a deep understanding to complex drug discovery projects.
With significant pharmaceutical business development, investment, and startup experience, these advisors work with researchers and technology transfer offices to develop commercialization strategies, support company creation, and identify and introduce potential investors and partners.